Pelthos Therapeutics target price cut by Oppenheimer to $59 from $64
PTHS•Oppenheimer cut its target price for Pelthos Therapeutics to $59 from $64.
Related News
Health in Tech Q3 2026 adjusted EBITDA swings to $3.9 million loss
HIT•
Mobility Global Inc.: Wells Fargo raises target price to $29 from $23
MBGL•
PAVmed says it is engaged with FDA on Portio and Octeris
PAVM•
Xenetic Biosciences Q3 royalty revenue falls 29% ahead of Santersus deal
XBIO•
Saudi Arabia's The Helicopter Company orders 12 Bombardier jets in fixed-wing aviation push
BBD•